Altimmune (ALT) EBT Margin (2010 - 2025)

Altimmune (ALT) has 16 years of EBT Margin data on file, last reported at 222653.85% in Q4 2025.

• On a quarterly basis, EBT Margin rose 68625385.0% year-over-year to 222653.85% in Q4 2025; TTM through Dec 2025 was 8600.0%, a 46669500.0% increase from a year earlier, with the FY2025 full-year figure at 8600.0%, up 46669500.0% from the prior year.
• EBT Margin for Q4 2025 stood at 222653.85%, up from 380280.0% in the prior quarter.
• Over the last five years, EBT Margin for ALT reached as high as 222653.85% in Q4 2025 and fell as low as 1185650.0% in Q3 2022.
• Historically, EBT Margin has averaged 247607.09% across 5 years, with a median of 173898.81% in 2022.
• Across the five-year window, EBT Margin slumped 116444114 bps in 2022 and jumped 117993978 bps in 2023, its largest moves.
• Year by year, EBT Margin stood at 164.24% in 2021, then slumped by 22148 bps to 36538.46% in 2022, then slumped by 134 bps to 85516.22% in 2023, then tumbled by 442 bps to 463600.0% in 2024, then surged by 148 bps to 222653.85% in 2025.
• Per Business Quant data, the three most recent EBT Margin figures were 222653.85% in Q4 2025, 380280.0% in Q3 2025, and 442920.0% in Q2 2025.